Clinical Trial Detail

NCT ID NCT02696993
Title Phase I/II Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

non-small cell lung carcinoma

Therapies

Nivolumab

Ipilimumab

Age Groups: adult

Additional content available in CKB BOOST